Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 12 studies | 24% ± 10% | |
lung | 8 studies | 27% ± 10% | |
brain | 7 studies | 26% ± 8% | |
eye | 5 studies | 24% ± 8% | |
liver | 4 studies | 29% ± 19% | |
pancreas | 3 studies | 28% ± 7% | |
kidney | 3 studies | 18% ± 1% | |
uterus | 3 studies | 28% ± 13% | |
bone marrow | 3 studies | 18% ± 1% | |
intestine | 3 studies | 26% ± 9% | |
lymph node | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3937.44 | 459 / 459 | 100% | 89.44 | 1118 / 1118 |
esophagus | 100% | 3176.43 | 1445 / 1445 | 100% | 58.99 | 183 / 183 |
lung | 100% | 3394.84 | 578 / 578 | 100% | 71.32 | 1155 / 1155 |
ovary | 100% | 3488.64 | 180 / 180 | 100% | 52.51 | 430 / 430 |
stomach | 100% | 2494.34 | 359 / 359 | 100% | 57.35 | 286 / 286 |
uterus | 100% | 3652.85 | 170 / 170 | 100% | 85.61 | 459 / 459 |
thymus | 100% | 3220.75 | 653 / 653 | 100% | 85.17 | 604 / 605 |
bladder | 100% | 3437.67 | 21 / 21 | 100% | 71.36 | 503 / 504 |
prostate | 100% | 2900.98 | 245 / 245 | 100% | 67.05 | 501 / 502 |
skin | 100% | 4500.19 | 1809 / 1809 | 100% | 84.88 | 471 / 472 |
brain | 100% | 2107.09 | 2630 / 2642 | 100% | 66.65 | 705 / 705 |
kidney | 100% | 2328.04 | 89 / 89 | 99% | 52.42 | 896 / 901 |
pancreas | 99% | 1796.95 | 326 / 328 | 100% | 67.92 | 178 / 178 |
intestine | 100% | 3323.42 | 966 / 966 | 99% | 65.37 | 523 / 527 |
liver | 100% | 1385.58 | 225 / 226 | 99% | 40.90 | 401 / 406 |
adrenal gland | 100% | 2757.05 | 258 / 258 | 98% | 54.22 | 225 / 230 |
adipose | 100% | 3975.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3489.46 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 91.03 | 29 / 29 |
muscle | 100% | 3339.56 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3694.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 79.30 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 35.15 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 69.98 | 79 / 80 |
peripheral blood | 99% | 2917.81 | 916 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 2128.39 | 848 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0030511 | Biological process | positive regulation of transforming growth factor beta receptor signaling pathway |
GO_0048385 | Biological process | regulation of retinoic acid receptor signaling pathway |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0070564 | Biological process | positive regulation of vitamin D receptor signaling pathway |
GO_0042771 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_0050769 | Biological process | positive regulation of neurogenesis |
GO_0048026 | Biological process | positive regulation of mRNA splicing, via spliceosome |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0043923 | Biological process | positive regulation by host of viral transcription |
GO_0048384 | Biological process | retinoic acid receptor signaling pathway |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0070562 | Biological process | regulation of vitamin D receptor signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0008024 | Cellular component | cyclin/CDK positive transcription elongation factor complex |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071007 | Cellular component | U2-type catalytic step 2 spliceosome |
GO_0016363 | Cellular component | nuclear matrix |
GO_0016604 | Cellular component | nuclear body |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0005112 | Molecular function | Notch binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0046332 | Molecular function | SMAD binding |
GO_0042974 | Molecular function | nuclear retinoic acid receptor binding |
GO_0003723 | Molecular function | RNA binding |
GO_0050681 | Molecular function | nuclear androgen receptor binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0042809 | Molecular function | nuclear vitamin D receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SNW1 |
Protein name | SNW domain containing 1 SNW domain-containing protein 1 (Nuclear protein SkiP) (Nuclear receptor coactivator NCoA-62) (Ski-interacting protein) SNW domain-containing protein 1 |
Synonyms | SKIP SKIIP |
Description | FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome . As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Required for the specific splicing of CDKN1A pre-mRNA; the function probably involves the recruitment of U2AF2 to the mRNA. May recruit PPIL1 to the spliceosome. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. Involved in transcriptional regulation. Modulates TGF-beta-mediated transcription via association with SMAD proteins, MYOD1-mediated transcription via association with PABPN1, RB1-mediated transcriptional repression, and retinoid-X receptor (RXR)- and vitamin D receptor (VDR)-dependent gene transcription in a cell line-specific manner probably involving coactivators NCOA1 and GRIP1. Is involved in NOTCH1-mediated transcriptional activation. Binds to multimerized forms of Notch intracellular domain (NICD) and is proposed to recruit transcriptional coactivators such as MAML1 to form an intermediate preactivation complex which associates with DNA-bound CBF-1/RBPJ to form a transcriptional activation complex by releasing SNW1 and redundant NOTCH1 NICD. .; FUNCTION: (Microbial infection) Is recruited by HIV-1 Tat to Tat:P-TEFb:TAR RNA complexes and is involved in Tat transcription by recruitment of MYC, MEN1 and TRRAP to the HIV promoter. .; FUNCTION: (Microbial infection) Proposed to be involved in transcriptional activation by EBV EBNA2 of CBF-1/RBPJ-repressed promoters. . FUNCTION: Involved in pre-mRNA splicing. . FUNCTION: Involved in pre-mRNA splicing. . FUNCTION: Involved in pre-mRNA splicing. . FUNCTION: Involved in pre-mRNA splicing. . FUNCTION: Involved in pre-mRNA splicing. . FUNCTION: Involved in pre-mRNA splicing. . |
Accessions | G3V3A4 Q6I9S2 ENST00000556428.5 ENST00000261531.12 ENST00000554324.1 Q6P151 G3V5R3 Q0D2M5 ENST00000555761.5 G3V4X8 ENST00000554775.5 G3V4E0 Q13573 |